In this article, Felicity Thomas, EPM editor, discusses connected solutions for drug delivery in the ophthalmic space and how this may help with patient adherence among other things with Fanny Sellier, from Nemera.
We speak with Christian Treitel, head of strategy & business development from Bosch about the company's innovations highlighted at the show, industry trends and what the future holds…
After catching our breath post-ACHEMA, we discuss* some of the innovations that were showcased during the massive German event and major industry trends both now and in the future with five key manufacturing companies who were all in attendance.
A brief round up of some of the latest developments in the industry, including a review into medical marijuana and a potential win for Trump in drug pricing…
As the pharma market is rocked by the news of Amazon’s acquisition of PillPack — the online pharmacy — we briefly take a look at the history of the e-commerce giant and what impact its move into pharma may have on the traditional space.
We speak with Javier Raposo, sales & marketing director from I Holland about the company's innovations highlighted at the show, industry trends and what the future holds…
Aflex Hose — a business division of Watson-Marlow Fluid Technology Group — has emphasized the importance of using products that are within the rules and comply with regulatory bodies’ specifications.
In this online exclusive, partners from Hogan Lovells International, Andreas von Falck and Miriam Gundt (Dusseldorf), discuss recent trends in patent protection within the pharmaceutical sector.
In response to the government’s Home Affairs Committee’s report on policy options for the future migration from the European Economic Area, Dr Sarah Main, executive director of the Campaign for Science and Engineering (CaSE) gives us her thoughts
A new survey from the manufacturers’ organisation, EEF, has demonstrated that manufacturers are becoming more fluent in their understanding of the fourth industrial revolution with more boosting investments, but further progress is required.
According to data and analytics company, GlobalData, personalised medicine is becoming an increasing possibility for patients as a result of newly developed algorithms and the use of big data.
During the International Aids Conference in Amsterdam, Dr Iain Barton, healthcare strategy executive at Imperial Logistics, gave a warning that more action is needed against the scourge of fake medicine in Africa.
